CTLA4 and neoplasm: TG6050, an oncolytic vaccinia virus (OVV) encoding IL-12 and anti-CTLA-4 (@CTLA-4), allowed prolonged intra-tumoral expression of IL-12 and @CTLA-4 at effective levels without systemic toxicity and promoted tumor regression through significant immune remodeling of the TME.122